2005
DOI: 10.1089/jwh.2005.14.609
|View full text |Cite
|
Sign up to set email alerts
|

Relative Antidepressant Efficacy of Venlafaxine and SSRIs: Sex-Age Interactions

Abstract: These findings provide further evidence that age, gender, and HRT moderate response to antidepressant medications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
117
0
6

Year Published

2007
2007
2015
2015

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 183 publications
(132 citation statements)
references
References 23 publications
9
117
0
6
Order By: Relevance
“…However, studies focused on SSRIs in larger patient populations, such as a study of citalopram in the Sequenced Treatment Alternatives to Relieve Depression, or STAR*D trial, document significantly larger treatment effects among women relative to men (Young et al 2009). Furthermore, differential effects of antidepressants by gender have been concentrated among patients under age 50, leading some to hypothesize that hormonal activity affects the efficacy of antidepressants (Thase et al 2005). These differences are too small to explain the dramatic effects for girls versus boys, though.…”
Section: Alternative Interpretation Of the Resultsmentioning
confidence: 99%
“…However, studies focused on SSRIs in larger patient populations, such as a study of citalopram in the Sequenced Treatment Alternatives to Relieve Depression, or STAR*D trial, document significantly larger treatment effects among women relative to men (Young et al 2009). Furthermore, differential effects of antidepressants by gender have been concentrated among patients under age 50, leading some to hypothesize that hormonal activity affects the efficacy of antidepressants (Thase et al 2005). These differences are too small to explain the dramatic effects for girls versus boys, though.…”
Section: Alternative Interpretation Of the Resultsmentioning
confidence: 99%
“…20 Women respond better to selective serotonin reuptake inhibitors than men. 22 Differences related to menopausal status have also been noted, with postmenopausal women responding more poorly to selective serotonin reuptake inhibitors than premenopausal women, 23 and premenopausal women responding poorly to tricyclic antidepressants. 24 Premenstrual disorders (PMD) are prototypical femalespecific disorders that include premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and premenstrual exacerbation (PME) of ongoing affective disorders such as dysthymia and major and minor depression.…”
Section: Depressive Disorders Including Premenstrual Disordersmentioning
confidence: 99%
“…Research is needed to determine whether comorbidities influence sex/gender differences in the effectiveness and side effects of specific treatments. For example, selective serotonin reuptake inhibitors (SSRIs) are more effective for women than for men for depression [106,197]; research is needed to determine whether this difference holds when SSRIs are used for pain. …”
mentioning
confidence: 99%